Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) – Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.


Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *